选择性激光小梁成形术与模式扫描激光小梁成形术的疗效与安全性:一项随机临床试验
该单中心随机对照试验纳入132例原发性开角型青光眼或高眼压症患者,1:1随机接受PSLT(n=65)或SLT(n=67),随访12个月。结果显示两组眼压下降幅度及安全性指标均无显著差异,PSLT在降眼压疗效和安全性方面未优于SLT。
要点
- PSLT与SLT在12个月内的眼压测量值相当,总体平均差0.4 mmHg(95%CI -0.5至1.3)。
- PSLT组治疗成功率15.4%,SLT组25.4%,差异10.0%(95%CI -3.6至23.6),无统计学意义。
- 基线眼压较高和术后第1天眼压下降百分比更大与12个月眼压下降百分比更大相关(p<0.001)。
核心结论
- 在POAG或OHT患者中,PSLT在安全性和降眼压疗效方面未优于SLT。
研究设计与样本
- 单中心随机对照试验,连续纳入132例POAG或OHT患者,1:1随机接受PSLT(n=65)或SLT(n=67)。
- 随访12个月,主要结局为12个月时无需降眼压药物且眼压下降≥20%的患者比例(完全成功)。
主要发现
- PSLT组和SLT组基线平均眼压分别为21.2±4.1 mmHg和21.3±4.7 mmHg(p=0.898)。
- 12个月时两组眼压分别为18.3±3.1 mmHg和17.8±3.4 mmHg(p=0.402),总体平均差0.4 mmHg(95%CI -0.5至1.3)。
- PSLT组15.4%和SLT组25.4%的患者达到治疗成功,差异10.0%(95%CI -3.6至23.6)(p=0.155)。
- 基线眼压较高和术后第1天眼压下降百分比更大与12个月眼压下降百分比更大相关(p<0.001)。
- 两组在基线及12个月随访时的视野平均偏差、平均视网膜神经纤维层厚度、角膜内皮细胞计数和视力均无显著差异(p≥0.062)。
关键数值与推荐
- 完全成功定义为12个月时无需降眼压药物且眼压下降≥20%。
- 治疗成功比例:PSLT组15.4%,SLT组25.4%,差异10.0%(95%CI -3.6至23.6),p=0.155。
临床怎么用
- PSLT可作为SLT的替代选择,但不应期望其在降眼压或安全性方面带来额外获益。
- 基线眼压较高及术后早期眼压下降明显的患者可能获得更好的12个月降眼压效果。
局限性
- 单中心研究,样本量有限(PSLT组65例,SLT组67例)。
- 随访时间为12个月,未报告更长期结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: To compare the intraocular pressure (IOP) lowering effect and safety profile between pattern scanning laser trabeculoplasty (PSLT) and selective laser trabeculoplasty (SLT) in patients with primary open-angle glaucoma (POAG) or ocular hypertension (OHT) over a 12-month follow-up. METHODS: 132 patients with POAG or OHT were consecutively enrolled and randomised (1:1) to receive PSLT (n=65) or SLT (n=67) in a single centre. IOP was measured before and then on 1 day, 1 week, 1, 3, 6, 9 and 12 months after PSLT/SLT. The primary outcome measure was the proportion of patients with ≥20% IOP reduction at 12 months without IOP-lowering medications (complete success). RESULTS: The mean baseline IOP was 21.2±4.1 mm Hg for eyes randomised to PSLT and 21.3±4.7 mm Hg for eyes randomised to SLT (p=0.898). At 12 months, the IOP was 18.3±3.1 and 17.8±3.4 mm Hg, respectively (p=0.402). IOP measurements were comparable between the groups over 12 months (overall mean difference 0.4 mm Hg, 95% CI: -0.5 to 1.3 mm Hg). 15.4% of PSLT-treated and 25.4% of SLT-treated patients achieved treatment success (difference: 10.0%, 95% CI: -3.6 to 23.6) (p=0.155), respectively. A higher baseline IOP and a greater percentage of IOP reduction at day 1 were associated with a greater percentage of IOP reduction at 12 months (p<0.001). There were no significant differences in visual field mean deviation, average retinal nerve fibre layer thickness, corneal endothelial cell count and visual acuity between the treatment groups at the baseline and 12-month follow-up (p≥0.062). CONCLUSIONS: PSLT was not superior to SLT in terms of safety and IOP-lowering efficacy in patients with POAG or OHT. TRIAL REGISTRATION NUMBER: The clinical trial was registered in the Centre for Research and Biostatistics Clinical Trials Registry, the Chinese University of Hong Kong (Identifier CUHK_CCT00407). The full trial protocol can be accessed from the authors on request.
引用
- Wong MOM, Lai IS, Chan PP, et al. Efficacy and safety of selective laser trabeculoplasty and pattern scanning laser trabeculoplasty: a randomised clinical trial. Br J Ophthalmol. 2020. PMID: 32606078. doi:10.1136/bjophthalmol-2020-316178
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。